New treatments of sickle cell disease.
Embury
S H
SH
D000755:Anemia, Sickle Cell / Q000503:physiopathology / Q000628:therapy*; D000986:Antisickling Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D015316:Genetic Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D011060:Poloxalene / Q000627:therapeutic use
D000986:Antisickling Agents; D011060:Poloxalene; D006918:Hydroxyurea